Nutrition
Volume 26, Issue 4 , Pages 349-353 , April 2010

Perioperative metabolic changes in patients undergoing cardiac surgery

  • Stephan M. Jakob, M.D., Ph.D.

      Affiliations

    • Department of Intensive Care Medicine, Bern University Hospital and University of Bern, Bern, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41-31-632-1176; fax: +41-31-632-9644.
    • ,
  • Zeno Stanga, M.D.

      Affiliations

    • Department of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital and University of Bern, Bern, Switzerland

Received 8 July 2009 ,Accepted 21 July 2009.

References 

  1. Chetty G, Sharpe DA, Nandi J, Butler SJ, Mitchell IM. Liver blood flow during cardiac surgery. Perfusion. 2004;19:153–156
  2. Atluri P, Kozin ED, Hiesinger W, Woo YJ. Off-pump, minimally invasive and robotic coronary revascularization yield improved outcomes over traditional on-pump CABG. Int J Med Robot. 2009;5:1–12
  3. Myles PS, Hunt JO, Fletcher H, Watts J, Bain D, Silvers A, et al. Remifentanil, fentanyl, and cardiac surgery: a double-blinded, randomized, controlled trial of costs and outcomes. Anesth Analg. 2002;95:805–812
  4. Pleym H, Stenseth R, Wiseth R, Karevold A, Dale O. Supplemental remifentanil during coronary artery bypass grafting is followed by a transient postoperative cardiac depression. Acta Anaesthesiol Scand. 2004;48:1155–1162
  5. Rapp-Kesek D, Stahle E, Karlsson T. Body mass index and albumin in the preoperative evaluation of cardiac surgery patients. Clin Nutr. 2004;23:1398–1404
  6. Imanaka K, Kyo S, Asano H, Ogiwara M, Kato M, Nishimura M, et al. Coronary artery bypass grafting in patients undergoing chronic hemodialysis: importance of wound healing and hypoproteinemia. J Cardiol. 2005;45:47–51
  7. Rady MY, Ryan T, Starr NJ. Clinical characteristics of preoperative hypoalbuminaemia predict outcome of cardiovascular surgery. JPEN. 1997;21:81–90
  8. Franch-Arcas G. The meaning of hypoalbuminaemia in clinical practice. Clin Nutr. 2001;20:265–269
  9. Turer AT, Stevens RD, Bain JR, Muehlbauer MJ, van der Westhuizen J, Mathew JP, et al. Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. Circulation. 2009;119:1736–1746
  10. Ulicny KS, Hiratzka LF. Nutrition and the cardiac surgical patient. Chest. 1992;101:836–842
  11. Karaca P, Konuralp C, Enc Y, Süzer A, Sokullu O, Ayoglu U, et al. Cardioprotective effect of aprotinin on myocardial ischemia/reperfusion injury during cardiopulmonary bypass. Circ J. 2006;70:1432–1436
  12. Khan TA, Bianchi C, Voisine P, Feng J, Baker J, Hart M, et al. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest. J Thorac Cardiovasc Surg. 2004;128:602–608
  13. Deja MA, Malinowski M, Gołba KS, Kajor M, Lebda-Wyborny T, Hudziak D, et al. Diazoxide protects myocardial mitochondria, metabolism, and function during cardiac surgery: a double-blind randomized feasibility study of diazoxide-supplemented cardioplegia. J Thorac Cardiovasc Surg. 2009;137:997–1004
  14. Jakob SM, Ruokonen E, Takala J. Assessment of the adequacy of systemic and regional perfusion after cardiac surgery. Br J Anaesth. 2000;84:571–577
  15. Ranucci M, De Toffol B, Isgrò G, Romitti F, Conti D, Vicentini M. Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit Care. 2006;10:R167
  16. Braun JP, Jakob SM, Volk T, Doepfmer UR, Moshirzadeh M, Stegmann S, et al. Arterio-venous gradients of free energy change for assessment of systemic and splanchnic perfusion in cardiac surgery patients. Perfusion. 2006;21:353–360
  17. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–454
  18. Kiyama T, Witte MB, Thornton FJ, Barbul A. The route of nutrition support affects the early phase of wound healing. JPEN. 1998;22:276–279
  19. Parviainen I, Rantala A, Ruokonen E, Tenhunen J, Takala J. Angiotensin converting enzyme inhibition has no effect on blood pressure and splanchnic perfusion after cardiac surgery. J Crit Care. 1998;13:73–80
  20. Ascione R, Rogers CA, Rajakaruna C, Angelini GD. Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery. Circulation. 2008;118:113–123
  21. Rajakaruna C, Rogers CA, Suranimala C, Angelini GD, Ascione R. The effect of diabetes mellitus on patients undergoing coronary surgery: a risk-adjusted analysis. J Thorac Cardiovasc Surg. 2006;132:802–810
  22. Tatlis A, Papakonstantinou C, Toumbouras M, Gerolioliou K, Spanos P. The effect of milrinone on metabolism after cardiopulmonary bypass. J Cardiovasc Surg. 2008;49:113–118
  23. Heringlake M, Wernerus M, Grünefeld J, Klaus S, Heinze H, Bechtel M, et al. The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting. Crit Care. 2007;11:R51
  24. Braun JP, Schroeder T, Buehner S, Jain U, Döpfmer U, Schuster J, et al. Small-dose epoprostenol decreases systemic oxygen consumption and splanchnic oxygen extraction during normothermic cardiopulmonary bypass. Anesth Analg. 2006;102:17–24
  25. Schiesser M, Muller S, Kirchhoff P, Breitenstein S, Schafer M, Clavien PA. Assessment of a novel screening score for nutritional risk in predicting complications in gastro-intestinal surgery. Clin Nutr. 2008;27:565–570
  26. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22:415–421
  27. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22:321–336
  28. Van Venrooij LMW, De Vos R, Bormeijer-Hoelen AMMJ, Haaring C, De Mol BAJM. Preoperative unintended weight loss and low body mass index in relation to complications and length of stay after cardiac surgery. Am J Clin Nutr. 2008;87:1656–1661
  29. Johansen N, Kondrup J, Plum LM, Bak L, Nørregaard P, Bunch E, et al. Effect of nutritional support on clinical outcome in patients at nutritional risk. Clin Nutr. 2004;23:539–550
  30. Schiesser M, Kirchhoff P, Müller MK, Schäfer M, Clavien PA. The correlation of nutrition risk index, nutrition risk score, and bioimpedance analysis with postoperative complications in patients undergoing gastrointestinal surgery. Surgery. 2009;145:519–526
  31. Cuthbertson DP. Symposium on surgery and nutrition. Historical approach. Proc Nutr Soc. 1980;39:101–105
  32. Griffiths RD. Too much of a good thing: the course of overfeeding. Crit Care. 2007;11:176
  33. Weimann A, Braga M, Harsanyi L, Laviano A, Ljungqvist O, Soeters P. ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr. 2006;25:224–244
  34. Windsor JA, Knight GS, Hill GL. Wound healing response in surgical patients: recent food intake is more important than nutritional status. Br J Surg. 1988;75:135–137
  35. Svanfeldt M, Thorell A, Hausel J, Soop M, Rooyackers O, Nygren J, et al. Randomized clinical trial of the effect of preoperative oral carbohydrate treatment on postoperative whole-body protein and glucose kinetics. Br J Surg. 2007;94:1342–1350
  36. Soop M, Nygren J, Thorell A, Weidenhielm L, Lundberg M, Hammarqvist F, et al. Preoperative oral carbohydrate treatment attenuates endogenous glucose release 3 days after surgery. Clin Nutr. 2004;23:733–741
  37. Vánky FB, Håkanson E, Jorfeldt L, Svedjeholm R. Does glutamate influence myocardial and peripheral tissue metabolism after aortic valve replacement for aortic stenosis?. Clin Nutr. 2006;25:913–922
  38. Tepaske R, Velthuis H, Oudemans-van Straaten HM, Heisterkamp SH, van Deventer SJ, Ince C, et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomized placebo-controlled trail. Lancet. 2001;358:696–701
  39. Revelly JP, Tappy L, Berger MM, Gersbach P, Cayeux C, Chiolero R. Early metabolic and splanchnic responses to enteral nutrition in postoperative cardiac surgery patients with circulatory compromise. Intensive Care Med. 2001;27:540–547
  40. Kesek DR, Akerlind L, Karlsson T. Early enteral nutrition in the cardiothoracic intensive care unit. Clin Nutr. 2002;21:303–307
  41. Hanninen SA, Darling PB, Sole MJ, Barr A, Keith ME. The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol. 2006;47:354–361
  42. Heyland DK, Dhaliwal R, Suchner U, Berger MM. Antioxidant nutrients: a systemic review of trace elements and vitamins in the critically ill patient. Intensive Care Med. 2005;31:327–337
  43. Soop M, Carlson GL, Hopkinson J, Clarke S, Thorell A, Nygren J, et al. Randomized clinical trial of the effects of immediate enteral nutrition on metabolic responses to major colorectal surgery in an enhanced recovery protocol. Br J Surg. 2004;91:1138–1145
  44. Lecomte P, Van Vlem B, Coddens J, Cammu G, Nollet G, Nobels F, et al. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Crit Care. 2008;12:R154
  45. Koskenkari JK, Kaukoranta PK, Kiviluoma KT, Raatikainen MJ, Ohtonen PP, Ala-Kokko TI. Metabolic and hemodynamic effects of high-dose insulin treatment in aortic valve and coronary surgery. Ann Thorac Surg. 2005;80:511–517
  46. NICE-SUGAR Study InvestigatorsFinfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–1297

PII: S0899-9007(09)00335-9

doi: 10.1016/j.nut.2009.07.014

Nutrition
Volume 26, Issue 4 , Pages 349-353 , April 2010

Article Tools